Episurf Medical to present at Redeye Life Science Day on November 23rd, 2023

Episurf Medical (Nasdaq: EPIS B) will attend Redeye Life Science Day which is held on November 23rd, 2023. The event is arranged by Redeye and the company will be represented by its CEO Pål Ryfors. The format will be a 2-minute Elevator Pitch followed by a 20-minute InFocus Q&A Session.

The presentation will be streamed live at 15:40 CET at https://www.redeye.se/events/915984/redeye-life-science-day-2023 and will also be made available afterwards on our website www.episurf.com.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on 23 November, 2023.